Authored by David M. Taylor and published by Wiley-Blackwell on June 14, 2021, The Maudsley Prescribing Guidelines in Psychiatry, now in its 14th Edition, stands as the essential, world-renowned reference guide for medication use in patients presenting with mental health problems. Identified by ISBN-10: 1119772222 and ISBN-13: 978-1119772224, this evidence-based handbook provides comprehensive guidance on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in daily clinical practice, this trusted resource offers expert advice on drug choice, minimum and maximum doses, adverse effects, switching medications, and prescribing for special patient groups. Each clear and concise chapter includes an up-to-date reference list, providing easy access to the evidence upon which the guidance is based. The fourteenth edition has been thoroughly updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections address crucial topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions from an experienced team of psychiatrists and specialist pharmacists, this latest edition of The Maudsley Prescribing Guidelines in Psychiatry continues its legacy as an indispensable tool for mental health professionals worldwide.